NCT05235906 2023-08-09
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
9 trialsNCT05705635 2023-01-31
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT04190745 2019-12-09
Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04121039 2019-10-09
Study of the Apatinib Combine With POF Versus POF in Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT02144727 2016-04-20
ADDICT
National Cancer Center, Korea
Phase 3 Unknown
NCT02512380 2015-08-10
Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer
ChineseAMS
Phase 3 Unknown
NCT01283217 2013-06-04
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer
Yonsei University
Phase 3 Unknown
NCT01641783 2012-07-17
Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients
The Third Affiliated Hospital of Harbin Medical University
Phase 2 Unknown
NCT01583361 2012-04-24
RESONANCE
Chinese PLA General Hospital
Phase 3 Unknown